About Claudia von Schilling Foundation for Breast Cancer Research Germany
The Claudia von Schilling Foundation for Breast Cancer Research Germany is a specialized medical research funder focused almost entirely on breast cancer (mammary carcinoma) and related therapeutic advances. It supports scientifically grounded projects ranging from novel treatment approaches and nanotechnology to palliative care, reconstruction using patient-derived tissue, and the dissemination of breast cancer research findings. Its grantees are typically university hospitals, oncology centers, and research institutes in Germany and Switzerland, with some international collaborations such as Harvard Medical School.
Focus Areas
Breast Cancer Translational ResearchNovel Breast Cancer TherapiesPalliative Care in OncologyBreast Reconstruction and Regenerative MedicineNanotechnology for Cancer Diagnosis and TreatmentAI-Enabled Cancer Research
Giving Approach
Competitive project grants for scientific research and therapeutic development; likely medium-sized research awards, awarded through announced calls or unsolicited proposals rather than a fixed public deadline, with emphasis on academic and clinical research partners in Germany and neighboring countries.
Want a Personalized Pitch for Claudia von Schilling Foundation for Breast Cancer Research Germany?
Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Weekly grant intelligence for social impact leaders. Curated opportunities, funding trends, and strategic insights — free.
Join 500+ social impact leaders. Unsubscribe anytime. Privacy Policy
Weekly grant intelligence in your inbox. No spam — unsubscribe anytime.
Cancel anytime
How to approach this funder
Watch the foundation website for announced calls, since no fixed public deadline is stated. Strong applications should be breast-cancer-specific, scientifically rigorous, and ideally involve academic medical centers or established oncology research groups in Germany, Switzerland, or international collaboration. Emphasize novel therapeutic relevance, translational impact, and clear alignment with the foundation’s breast cancer mission.
Notable grantees:
• Medizinische Hochschule Hannover (MHH)
• Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Molekulare und Zelluläre Onkologie
• Fraunhofer-Institut für Mikrotechnik und Mikrosysteme (IMM)
• Universitätsspital Basel
• Harvard Medical School
Open Grant Opportunities
Current and upcoming funding from Claudia von Schilling Foundation for Breast Cancer Research Germany that your nonprofit may be able to apply for.
Open nowAward: Up to $12K
Claudia von Schilling-Preis
Breast cancer medicineBreast cancer treatmentCancer basic research
Who can apply: The prize is preferably, but not exclusively, intended for scientists in the German-speaking region who have made exceptional contributions to breast cancer medicine or relevant cancer basic research. The foundation makes the award at its discretion and no legal entitlement exists.
Deadline: The current call is available, but no application deadline is stated in the scraped content.
Breast cancer medicineBreast cancer therapyBreast cancer research
Who can apply: The award is intended for young, promising scientists and research groups. Recipients should generally be no older than 40 when completing the work submitted for the award. Eligible work must be notable and concern breast cancer medicine, therapy or research. The foundation decides at its discretion and no legal entitlement exists.
Deadline: The current call is available, but no application deadline is stated in the scraped content.
breast cancer researchoncology researchtranslational research+4 more
Who can apply: Projects must fit the foundation’s statutory purpose and scientific scope. Applications should generally follow relevant research proposal guidelines (e.g., DFG-style requirements) and include project title, applicants, detailed project description, research status, and scope/duration of planned measures. For joint applications, one legally responsible applicant must be named; applicants should include a CV and publication record. A short concept may be sufficient for initial review in some cases.
Deadline: No fixed deadline stated; projects can be presented outside a call for proposals.
Breast cancer treatment and therapyBreast cancer basic and clinical researchNovel therapeutic approaches+7 more
Who can apply: Projects must fall within the foundation's statutory purposes and be scientifically meaningful, particularly in breast cancer medicine, relevant cancer basic research, new therapeutic procedures or palliative medicine. Applications must include the working title, applicants, detailed project description, state of research, and the nature, scope and duration of requested measures. For joint applications, the legally responsible applicant and person responsible for administering funds must be identified. Applicants must provide a scientific CV and evidence of previous publications. Applications should follow relevant guidelines, such as German Research Foundation (DFG) requirements.
Deadline: No fixed deadline stated; eligible projects may also be submitted outside a formal call.
Deadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.